Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 68071-3727

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 68071-3727). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Pdp (68071 3727 9)

Pdp (68071 3727 9)
Label for Venlafaxine Hydrochloride 150 mg extended-release capsules by NuCare Pharmaceuticals Inc. The label indicates a quantity of 90 capsules (E-R), prescription only. It includes manufacturing details from Granules India Limited, patient instructions to take every specified hours daily, and warnings to keep out of reach of children and store at controlled temperatures (68-77°F). Barcode and batch information are also present.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
A scatter plot showing fold changes and 90% confidence intervals for venlafaxine and its metabolite ODV under various special population conditions, including hepatic and renal impairments, CYP2D6 metabolizer status, age, and gender. The x-axis represents change relative to the reference value, with multiple data points for Cmax and AUC pharmacokinetic parameters.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A scatter plot chart showing fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax, AUC) of venlafaxine and its metabolite ODV relative to various interacting drugs. The x-axis represents change relative to a reference value, and the y-axis lists interacting drugs including ethanol, diazepam, cimetidine, ketoconazole, indinavir, metoprolol, imipramine, and lithium.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A scatter plot graph depicting fold changes and 90% confidence intervals for various interacting drugs and analytes, showing their effect on pharmacokinetic parameters (Cmax and AUC) relative to a reference value. The compounds include Ethanol, Diazepam, Alprazolam, Indinavir, Metoprolol, Risperidone, Imipramine, Haloperidol, Caffeine, Tolbutamide, and Lithium, with fold change values ranging approximately between 0.5 and 2.5.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of venlafaxine hydrochloride, depicting its molecular arrangement including aromatic ring, cyclohexane ring, and functional groups with the hydrochloride salt indicated.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.